Brief: Clinical Study Shows Usana Celavive's Resurfacing Serum To Improve Appearance Of Skin In Just Two Weeks
14/04/2025 12:30
April 14 (Reuters) - USANA Health Sciences Inc USNA.N: CLINICAL STUDY SHOWS USANA CELAVIVE'S RESURFACING SERUM TO IMPROVE APPEARANCE OF SKIN IN JUST TWO WEEKS Source text: ID:nPn1yhZ0la Further company coverage: USNA.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview